Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TCM core prescription refers to a specific multi-herb Traditional Chinese Medicine (TCM) decoction developed for the treatment of sepsis-induced cardiomyopathy (SIC). In the context of clinical research conducted by the Guangdong Provincial Hospital of Chinese Medicine, this prescription consists of seven traditional herbs: Huangqi (Astragalus membranaceus), Danshen (Salvia miltiorrhiza), Shu Fuzi (Aconitum carmichaelii), Danggui (Angelica sinensis), Chuanxiong (Ligusticum striatum), Fuling (Poria cocos), and Dahuang (Rheum palmatum). The formula is designed to address the complex pathophysiology of SIC, which involves systemic inflammation, oxidative stress, and myocardial depression. Its mechanism of action is multi-targeted, typically involving the modulation of inflammatory cytokines, reduction of myocardial injury, and improvement of microcirculation. The decoction is administered as an adjunct to conventional Western medical treatment, often via oral or nasal feeding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on TCM core prescription.